[Cardiovascular prevention according to CEIPC: a critical appraisal]

Area of Science:

• Cardiology
• Public Health
• Clinical Practice Guidelines

Background:

• The Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention (CEIPC) adapted the 4th European Guidelines on Cardiovascular Disease Prevention.
• This adaptation involves significant deviations from the original European recommendations.

Purpose of the Study:

• To critically appraise the CEIPC's adaptation of the European Cardiovascular Disease Prevention Guidelines.
• To identify and evaluate clinical recommendations lacking sufficient evidence.
• To assess transparency and conflicts of interest in guideline development.

Main Methods:

• Critical analysis of the CEIPC adaptation document.
• Comparison of CEIPC recommendations with the original European guidelines.
• Review of supporting clinical evidence for key recommendations.

Main Results:

• The CEIPC adaptation removed restrictions on initiating drug therapy.
• Internal contradictions exist regarding LDL cholesterol goals.
• There is a lack of discussion on cardiovascular risk tables specific to Spain.
• Several recommendations, including cardiovascular risk as a treatment target, antihypertensive therapy initiation, and targets for blood pressure, LDL-cholesterol, and HbA1c, are not well-supported by clinical evidence.

Conclusions:

• The CEIPC adaptation presents several evidence-based concerns regarding cardiovascular disease prevention strategies.
• Transparency, independence, and conflict of interest declarations are crucial for public health documents.
• Scientific societies and public health administrations must ensure honesty and rigor in guideline development.